DD148585A5 - Verfahren fuer die erhoehung der wirksamkeit einer pharmazeutischen zusammensetzung - Google Patents

Verfahren fuer die erhoehung der wirksamkeit einer pharmazeutischen zusammensetzung Download PDF

Info

Publication number
DD148585A5
DD148585A5 DD78218400A DD21840078A DD148585A5 DD 148585 A5 DD148585 A5 DD 148585A5 DD 78218400 A DD78218400 A DD 78218400A DD 21840078 A DD21840078 A DD 21840078A DD 148585 A5 DD148585 A5 DD 148585A5
Authority
DD
German Democratic Republic
Prior art keywords
penicillanic acid
phenylacetamido
acid
amino
acetamido
Prior art date
Application number
DD78218400A
Other languages
German (de)
English (en)
Inventor
Wayne E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DD148585(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of DD148585A5 publication Critical patent/DD148585A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD78218400A 1977-06-07 1978-06-07 Verfahren fuer die erhoehung der wirksamkeit einer pharmazeutischen zusammensetzung DD148585A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (1)

Publication Number Publication Date
DD148585A5 true DD148585A5 (de) 1981-06-03

Family

ID=27122691

Family Applications (2)

Application Number Title Priority Date Filing Date
DD78205839A DD140888A5 (de) 1977-06-07 1978-06-07 Verfahren zur herstellung von penicillansaeure-1,1-dioxidderivaten
DD78218400A DD148585A5 (de) 1977-06-07 1978-06-07 Verfahren fuer die erhoehung der wirksamkeit einer pharmazeutischen zusammensetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD78205839A DD140888A5 (de) 1977-06-07 1978-06-07 Verfahren zur herstellung von penicillansaeure-1,1-dioxidderivaten

Country Status (35)

Country Link
AR (1) AR224111A1 (es)
AT (2) AT360649B (es)
AU (1) AU513636B2 (es)
BE (1) BE867859A (es)
BG (2) BG34614A3 (es)
CH (1) CH634073A5 (es)
CS (1) CS208472B2 (es)
DD (2) DD140888A5 (es)
DE (2) DE2824535C3 (es)
DK (1) DK155740C (es)
EG (1) EG13869A (es)
FI (1) FI66003C (es)
FR (2) FR2393804A1 (es)
GB (1) GB2000138B (es)
GR (1) GR72255B (es)
HK (1) HK13184A (es)
HU (1) HU180042B (es)
IE (1) IE47079B1 (es)
IL (2) IL54867A (es)
IN (1) IN149747B (es)
IT (1) IT1096381B (es)
KE (1) KE3355A (es)
LU (1) LU79774A1 (es)
MY (1) MY8500092A (es)
NL (2) NL180009C (es)
NO (2) NO151746C (es)
NZ (1) NZ187476A (es)
OA (1) OA05964A (es)
PH (3) PH26810A (es)
PL (1) PL114501B1 (es)
PT (1) PT68146A (es)
SE (2) SE436206B (es)
SG (1) SG65383G (es)
SU (1) SU860706A1 (es)
YU (1) YU41829B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (es) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IL59948A0 (en) * 1979-05-21 1980-06-30 Rech Applications Therap Penicillanic acid derivatives,their production and pharmaceutical compositions containing them
DE3051044C2 (es) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
DE3261759D1 (en) * 1981-07-15 1985-02-14 Kanebo Ltd Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
WO1987006230A1 (en) * 1986-04-10 1987-10-22 Leo Pharmaceutical Products Ltd. A/S Method for preparing penicillanic acid derivatives
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (es) * 1977-05-09 1979-01-18
EP0000636A1 (en) * 1977-07-13 1979-02-07 Glaxo Group Limited Penem compounds, processes for their preparation, their use in pharmaceutical compositions and azetidinones used in their preparation

Also Published As

Publication number Publication date
DE2824535A1 (de) 1978-12-14
GB2000138B (en) 1982-03-03
DK155740C (da) 1989-10-23
PT68146A (en) 1978-07-01
NO151746C (no) 1985-06-05
SE8305916L (sv) 1983-10-27
AU513636B2 (en) 1980-12-11
DK251478A (da) 1978-12-08
FR2393805A1 (fr) 1979-01-05
IE47079B1 (en) 1983-12-14
NO151746B (no) 1985-02-18
AT360649B (de) 1981-01-26
BE867859A (fr) 1978-12-06
HK13184A (en) 1984-02-24
NO781970L (no) 1978-12-08
DK155740B (da) 1989-05-08
PH21116A (en) 1987-07-16
EG13869A (en) 1983-03-31
PH16465A (en) 1983-10-20
IT7824270A0 (it) 1978-06-06
AR224111A1 (es) 1981-10-30
NL180009C (nl) 1986-12-16
IL62168A0 (en) 1981-03-31
NO152448C (no) 1985-10-02
IT1096381B (it) 1985-08-26
CH634073A5 (en) 1983-01-14
CS208472B2 (en) 1981-09-15
NZ187476A (en) 1982-08-17
LU79774A1 (fr) 1980-01-22
SU860706A1 (ru) 1981-08-30
DE2824535C3 (de) 1981-01-22
IN149747B (es) 1982-04-03
MY8500092A (en) 1985-12-31
SE436206B (sv) 1984-11-19
KE3355A (en) 1983-12-16
BG34614A3 (en) 1983-10-15
FR2393804A1 (fr) 1979-01-05
SE447995B (sv) 1987-01-12
NL7806126A (nl) 1978-12-11
YU117078A (en) 1983-01-21
IL54867A0 (en) 1978-08-31
SE8305916D0 (sv) 1983-10-27
PL207396A1 (pl) 1979-06-04
ATA128580A (de) 1981-02-15
IE781140L (en) 1978-12-07
SE7806628L (sv) 1978-12-08
FR2393804B1 (es) 1980-11-07
FI781800A (fi) 1978-12-08
DE2824535B2 (de) 1980-05-14
NO152448B (no) 1985-06-24
DE2857263C3 (de) 1981-12-17
GR72255B (es) 1983-10-06
AU3683878A (en) 1979-12-06
FR2393805B1 (es) 1984-02-24
OA05964A (fr) 1981-06-30
PH26810A (en) 1992-11-05
AT364084B (de) 1981-09-25
FI66003C (fi) 1984-08-10
NO823126L (no) 1978-12-08
ATA411278A (de) 1980-06-15
FI66003B (fi) 1984-04-30
PL114501B1 (en) 1981-02-28
HU180042B (en) 1983-01-28
GB2000138A (en) 1979-01-04
BG34615A3 (en) 1983-10-15
IL54867A (en) 1981-11-30
SG65383G (en) 1985-03-29
DD140888A5 (de) 1980-04-02
NL930064I2 (nl) 1994-04-18
DE2857263B2 (de) 1981-04-23
NL930064I1 (nl) 1993-09-01
YU41829B (en) 1988-02-29

Similar Documents

Publication Publication Date Title
DD148585A5 (de) Verfahren fuer die erhoehung der wirksamkeit einer pharmazeutischen zusammensetzung
DE2559411A1 (de) Arzneimittelgemische
DE2250993A1 (de) Antibakterielles mittel
DE3051037C2 (es)
DE69532032T2 (de) Pharmazeutische formulierung, die ein beta-lactamase hemmendes penem in kombination mit einem beta-laktam-antibiotikum enthalten und ihre verwendung zur behandlung von bakteriellen infektionen
DE3008316C2 (de) 6-β-Jodpenicillansäure-Derivate, Verfahren zu ihrer Herstellung und solche Derivate enthaltende Arzneimittel
DD153123A5 (de) Verfahren zur herstellung einer penam-1,1-dioxid-verbindung
AT395590B (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
CH626370A5 (en) Process for the preparation of the syn isomer or of a mixture of syn and anti isomers of 7beta-acylamidoceph-3-em-4-carboxylic acids with antibiotic activity
EP0004925A1 (de) Synergistische Mischungen von Antibiotika und Verfahren zu ihrer Herstellung
EP0000380A1 (de) Penicilline, Verfahren zu ihrer Herstellung und ihre Verwendung
DD234015A5 (de) Verfahren zur herstellung von 6-(subst.)-methylen-penicillan-und 6-(subst.)-hydroxymethyl-penicillansaeure und deren derivaten
DD218365A5 (de) Verfahren zur herstellung von 6-aminomethylpenicillansaeure-1,1-dioxid-derivaten als beta-lactamase-inhibitoren
EP0548790B1 (de) (1'S)-Hydroxyalkyloxapenem-3-carbonsäuren und ihre Verwendung als Betalactamasehemmer
DE2600880A1 (de) Neue cephalosporine, verfahren zur herstellung derselben und mittel mit einem gehalt derselben
DE2910907C2 (de) Antibakterielles Mittel
DE2846713A1 (de) Cephalosporine, ihre herstellung und sie enthaltende arzneimittel
DE3302335A1 (de) Ss-lactamverbindungen, ihre herstellung und sie enthaltendes arzneimittel
DD149528A5 (de) Verfahren zur herstellung von neuen beta-lactam-verbindungen
US4203972A (en) Penicillin composition
US4427678A (en) 6-Aminomethylpenicillanic acid 1,1-dioxide derivatives as beta-lactamase inhibitors
US4898731A (en) Antibiotic combinations of penicillins
US4221781A (en) Synergistic penicillin-cephalosporin compositions and methods
CA1132046A (en) Combinations of penicillanic acid 1,1-dioxide with 7-(d-2-¬4-ethylpiperazin-2,3-dione-1- carboxamido|-2-¬4-hydroxyphenyl|acetamido) -3-(¬1-methyl-5-tetrazolyl|thiomethyl) -3-desacetoxymethylcephalosporanic acid
AT359195B (de) Verfahren zur herstellung von neuen cephalos- porinverbindungen und deren pharmazeutisch anwendbaren salzen